WESTBOROUGH, Mass. — Olympus Corporation (Olympus), a global MedTech company committed to advancing endoscopy-enabled care, today announced an exclusive global distribution agreement with Endocision for a portable, single-use flexible cryocatheter system.
Under the agreement, Olympus will serve as the exclusive global distributor of the Endocision platform designed to support a variety of diagnostic and therapeutic bronchoscopic procedures. Olympus and Endocision expect commercial launch in the U.S., Canada and Europe early next year.
The agreement will expand and enhance Olympus’ respiratory portfolio, which includes endobronchial ultrasound (EBUS) that plays a key role in the visualization and biopsy of lung tissue and lymph nodes.